The potential impact of the 13-valent conjugate pneumococcal vaccine on antibiotic resistance in pneumococci

References

• Hansman D, Mullen MM. A resistant pneumococcus. Lancet.1967;ii:264–265.
   Google Scholar
• MultiLocusSequenceTyping [homepage on the Internet]. c2010. Available from: www.mIstnet
   Google Scholar
• McGee L, McDougal L, Zhou J, et al. Nomenclature of major antimicrobial-resistant clones of Streptococcus pneumoniae defined by the Pneumococcal Molecular Epidemiology Network. J Clin Microbiol. 2001;39(7):2565–2571.
   Google Scholar
• Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev. 1990;3(2):1 71-196.
   Google Scholar
• Hicks LA, Harrison LH, Flannery B, et al. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination 1998-2004. J Infect Dis. 2007;196(9):1346–1354.
   Google Scholar
• Dagan R, Klugman KP. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis. 2008;8(12):785–795.
   Google Scholar
• Franco CM, Andrade AL, Andrade JG, et al. Survey of nonsuceptible nasopahryngeal Streptococcus pneumoniae isolates in children attending day-care centers in Brazil. Pediatr Infect Dis J. 2010;29(1):77–79.
   Google Scholar
• Batuwanthudawe R, Karunarathne K, Dassanayake M, et al. Surveillance of invasive pneumococcal disease in Colombo, Sri Lanka. Clin Infect Dis. 2009;48(Suppl 2):S136–S140.
   Google Scholar
• Castaneda E, Agudelo Cl, Regueira M, et al. Laboratory-based surveillance of Streptococcus pneumoniae invasive disease in children in 10 Latin American countries: a SIREVA ll project, 2000-2005. Pediatr Infect Dis J. 2009;28(9):e265–e270.
   Google Scholar
• Porat N, Barkai G, Jacobs MR, et al. Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in Southern Israel. J Infect Dis. 2004;189(3):385–392.
   Google Scholar
• Ramirez M, Tomasz A. Acquisition of new capsular genes among clinical isolates of antibiotic-resistant Streptococcus pneumoniae. Microb Drug Resist 1999;5(4):241–246.
   Google Scholar
• Moore CE, Sengduangphachanh A, Thaojaikong T, et al. Enhanced determination of Streptococcus pneumoniae serotypes associated with invasive disease in Laos by using a real-time polymerase chain reaction serotyping assay with cerebrospinal fluid. Am J Trop Med Hyg. 2010;83(3):451–457.
   Google Scholar
• Hanage WP, Fraser C, Tang J, et al. Hyper-recombination, diversity, and antibiotic resistance in pneumococcus. Science. 2009;324(5933):1454–1457.
   Google Scholar
• Johnsborg O, Harvastein LS. Regulation of natural genetic transforamtion and acquisition of transforming DNA in Streptococcus pneumoniae. FEMS Microbiol Rev. 2009;33(3):627–642.
   Google Scholar
• Reinert RR. The antimicrobial resistance profile of Streptococcus pneumoniae. Clin Microbiol Infect. 2009;15(Suppl 3):7–11.
   Google Scholar
• Katsarolis I, Poulakou G, Analitis A, et al. Risk factors for nasopharyngeal carriage of drug-resistant Streptococcus pneumoniae: data from a nation-wide surveillance study in Greece. BMC Infect Dis. 2009;9:120.
   Google Scholar
• Centers for Disease Control and Prevention. Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23). MMWR Morb Mortal Wkly Rep. 2010;59(34):1102–1106.
   Google Scholar
• Okeke IN, Klugman KP, Zulfiqar AB, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005;5(9):568–58.0
   Google Scholar
• Pallares R, Gudiol F, Linares J, et. al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med. 1987;317(1):18–22.
   Google Scholar
• Dagan R, Givon-Lavi N, Leibovit E, et al. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause otitis media in an unvaccinated population. J Infect Dis. 2009;199(6):776–785.
   Google Scholar
• Skalet A, Cevallos V, Ayele B, et al. Antibiotic selection pressure and macrolide resistance in nasopharyngeal streptococcus pneumoniae: a cluster -randomised trial. 7th international symposium on pneumococci and pneumococcal diseases. Tel Aviv, Israel: 2010.
   Google Scholar
• Grivea IN, Tsantouli AG, Chryssanthopoulou DN, Syrogiannopoulos GA. Interaction of the heptavalent pneumococal conjugate vaccine and the use of individual antibiotics among children on nasopharyngeal colonization with erythromycin-resistant Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis. 2010;29(1):97–105.
   Google Scholar
• Rueda AM, Serpa JA, Matloobi M, et al. The spectrum of invasive pneumococcal disease at an adult tertiary care hospital in the early 21st century. Medicine (Baltimore). 2010;89(5):331–336.
   Google Scholar
• Pemba L, Charalambous S, von Gottberg A, et al. Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolatees among HIV-infected mine workers in South Africa. J Infect Dis. 2008;56(3):171–178.
   Google Scholar
• Gill CJ, Mwanakasale V, Fox MP et al. Effect of presumptive co-trimoxazole prophylaxis on pneumococcal colonisation rates, seroepidemiology and antibiotic resistsnce in Zambian infants: a longitudinal cohort study. Bull World Health Organ. 2008;86(12):929–938.
   Google Scholar
• Coignard AB. Recent trends in antimicrobial resitance among Streptococcus pneumoniae and Staphylococcus aureus isolates: The French experience. Eur Surveil!. 2008;13(46).pii 19035.
   Google Scholar
• Black SB, Shinefiled HR, Ling S, et al. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years for prevention of pneumonia. Pediatr Infect Dis J. 2002;21(9):810–815.
   Google Scholar
• Klugman KP, Madhi, SA, Huebner RE, et al . A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. New Eng J Med. 2003;349(14):1341–1348.
   Google Scholar
• Cutts FT, Zaman SM, Enwere G, et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet. 2005;365(9465):1139–1146.
   Google Scholar
• Kyaw MH, Lynfield R, Schaffner W, et al. Effect of the introduction of the pneumococcal conjugate vaccine on drug-resistant streptococcus pneumoniae. New Eng J Med. 2006;354(14):1455–1463.
   Google Scholar
• Cohen R, Levy C, De La Rocque F, et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J. 2006;25(11):1001–1007.
   Google Scholar
• Fireman B, Black SE, Shinefield HR, et al. Impact of the pneumoccoccal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22(1):10–6.
   Google Scholar
• Dagan R, Sikuler-Cohen M, Zamir 0, et al. Effect of a conjugate vaccine on the occurence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J. 2001;20(10):951–958.
   Google Scholar
• Zhou F, Shefer A, Kong Y, Nuorti J P. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997–2004. Pediatrics. 2008;121(2):253–260.
   Google Scholar
• Van Effeltere T, Moore MR, Fierens F, et al. A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination. Vaccine. 2010;28(21):3650–3660.
   Google Scholar
• Park IH, Moore MR, Treanor JJ, et al. Differential effects of pneumococcal vacines against serotypes 6A and 6C. J Infect Dis. 2008;198(12):1818–1822.
   Google Scholar
• Pelton SI, Huot H, Finkelstein JA, et al. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2007;26(6):468–472.
   Google Scholar
• Bettinger JA, Scheifele DW, Kellner JD, et al. The effect of routine vaccination on invasive pneumococcal infections in Canadian children, Immunization Monitoring Program, Active 2000-2007. Vaccine. 2010;28(9):2130–2136.
   Google Scholar
• Isaacman DJ, McIntosh DE, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14(3):e197–e209.
   Google Scholar
• Cheung Y-B, Zaman SMA, Nsekpong ED, et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and their younger siblings. Pediatr Infect Dis J. 2009;28(11):990–995.
   Google Scholar
• Dagan R, Givon-Lavi N, Zamir O, et al. Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis. 2002;185(7):927–936.
   Google Scholar
• Givon-Lavi N, Fraser D, Dagan R. Vaccination of day care centre attendees reduces carriage of Streptococcus pneumoniae among their younger siblings. Pediatr Infect Dis J. 2003;22(6):524–532.
   Google Scholar
• Mera RM, Miller LA, Amrine-Madsen H, Sahm DF. The impact of the pneumococcal conjugate vaccine on antimicrobial resistance in the United States since 1996: evidence for a significant rebound by 2007 in many classes of antibiotics. Microb Drug Resist. 2009;15(4):261–268.
   Google Scholar
• Tyre!! GJ, Lovgren M, Chui N, et al. Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae pre- and post-seven valent pneumococcal vaccine introduction in Alberta, Canada, 2000-2006. Vaccine. 2009;27(27):3553–3560.
   Google Scholar
• Horcajada F, Canas AM, Alamo I, et al. Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands). Enferm Infecc Microbiol Clin. 2009;27(1):14–21.
   Google Scholar
• O'Brien KL, Millar EV, Zell ER, et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonisation among immunized and unimmunized children in a community randomized trial. J Infect Dis. 2007;196(8):1211–1220.
   Google Scholar
• Mbelle N, Huebner RE, Wasas AD, et al. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 1999;180(4):1171–1176.
   Google Scholar
• Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet. 1996;348(9022):271–272.
   Google Scholar
• Gray BM, Converse GM 3rd, and Dillon HC Jr. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage and infection during the first 24 months of life. J Infect Dis.1980;142(6):923–933.
   Google Scholar
• Hill CP, Townsend J, Antonio M, et al. Transmission of streptococcus pneumoniae in rural Gambian villages: a longitudinal study. Clin Infect Dis. 2010;50(11):1468–1476.
   Google Scholar
• Millar EV, Watt JP, Bronsdon MA, et al. Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonisation among unvaccinated household members. Clin Infect Dis. 2008;47(8):989–996.
   Google Scholar
• Huang SS, Hinrichsen, VL, Stevenson AE, et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics. 2009;124(1):el -e11.
   Google Scholar
• Moore MR, Gertz RE, Woodbury RL, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States. J Infect Dis. 2008;197(7):1016–1027.
   Google Scholar
• Techasaensiri C, Messina AF, Katz K, et al. Epidemiology and evolution of invasive pneumococcal disease caused by multidrug resistant serotypes of 19A in the 8 years after implementation of pneumococcal conjugate vaccine immunisation in Dalalas, Texas. Pediatr Infect Dis J. 2010;29(4):294–300.
   Google Scholar
• Kaplan SL, Barson WJ, Lin PL, et al. Serotype 19A is the most common serotype causing invasive pneumococcal infections in children. Pediatrics. 2010;125(3):429–436.
   Google Scholar
• Farell DJ, Klugman KP, Pichichero M. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States. Pediatr Infect Dis J. 2007;26(2):123–128.
   Google Scholar
• Ritcher SS, Heilmann KP, Dohrn CL, et al. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis. 2009;48(3):e23–33.
   Google Scholar
• Munoz-Almagro C, Esteva C, de Sevilla ME, et al. Emergence of invasive disease caused by multidrug-resistant serotype 19A among children in Barcelona. J Infect 2009;59(2):75–82.
   Google Scholar
• Picazo JJ. Management of antibiotic-resistant Streptococcus pneumoniae infections and the use of pneumococcal conjugate vaccines. Clin Microbiol Infect 2009;15(Suppl 3):4–6.
   Google Scholar
• Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitits. N Engl J Med. 2009;360(3):244–256.
   Google Scholar
• Hsu KK, Shea KM, Stevenson AE, et al. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001-2007. Pediatr Infect Dis J. 2010;29(4):289–293.
   Google Scholar
• Xue L, Yao K, Xie G, et al. Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates that cause invasive disease among Chinese children. Clin Infect Dis. 2010;50(5):741–744.
   Google Scholar
• Choi EH, Kim SH, Eun BW, et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg Infect Dis. 2008;14(2):275–281.
   Google Scholar
• Grijalva CG, Nuorti PJ, Griffin MR. Antibiotic prescription rates for acute respiratorytract infections in US ambulatroy settings. JAMA. 2009;302(7):758–766.
   Google Scholar
• Brueggemann AB, Pai R, Crook DW, Beall B. Vaccine escape recombinants emerge after pneumococcal vacciantion in the United States. PLoS Pathog. 2007;3(11):1628–1636.
   Google Scholar
• Van Gils EJ, Veenhoven RH, Hak E, et al. Pneumococcal conjugate vaccination and nasopharyngeal acquisition of pneumococcal serotype 19A strains. JAMA. 2010;304(10):1099–1106.
   Google Scholar
• Gertz REJ, Li Z, Pimenta FC, et al. Increased penicillin nonsusceptibility of non vaccine serotype invasive pneumococci other than serotype 19A and 6A in post-7-valent conjugate vaccine era. J Infect Dis. 2010;201(5):770–775.
   Google Scholar
• Cooper D, Yu X, Sidhu M, et al. 13-valent pneumococcal vaccine elicits strong opsonoghagocytic killing (opa) activity to Streptococcus pneumoniae serotypes 6A, 6B and 6C. 7th International Symposiun on Pneumococci and Pneumococcal Disease. Tel Aviv, Israel: 2010; p.267–278.
   Google Scholar
• Carvalho Mda G, Pimenta FC, Gertz RE, et al. PCR-based quantitation and clonal diversity of the current prevalent invasive serogroup 6 pneumococcal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol. 2009;47(3):554–559.
   Google Scholar
• Campos LC, Carvalho Mda G, Beall BW, et al. Prevalence of Streptococcus pneumoniae serotype 6C among invasive and carriage isolates in metropolitan Salvador, Brazil, from 1996 to 2007. Diagn Microbiol Infect Dis. 2009;65(2):112–115.
   Google Scholar
• Fenoll A, Granizo JJ, Aguilar L, et al. Temporal trends in invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979-2007. J Clin Microbiol. 2009;47(4):1012–1020.
   Google Scholar
• Frazao N, Brito-Avo A, Simas C, et al. Effect of the seven-valent conjugate pneumococcal vaccine on carriage and drug resistance of Streptococcus pneumoniae in healthy children attending day-care centres in Lisbon. Pediatr Infect Dis J. 2005;24(3):242–252.
   Google Scholar
• Sa-Leao R, Nunes S, Brito-Avo A, et al. Changes in pneumococcal serotypes and antibiotypes carried by vaccianted and unvaccinated day-care centre attendees in Portugal, a country with widespread use of the seven-valent pneumococcal conjugate vaccine. Clin Microbiol Infect. 2009;15(11):1002–1007.
   Google Scholar
• Leach AJ, Morris PS, McCallum GB, et al. Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001. BMC Infect Dis. 2009;9:121.
   Google Scholar
• Bryant KA, Block SA, Gruber WC, Scott DA. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics. 2010;125(5):866–875.
   Google Scholar
• Centers for Disease Control and Prevention. Invasive pneumococcal disease in young children before licensure of 13 valent pneumococcal conjugate vaccine: United States, 2007. MMWR Morb Mortal Wkly Rep. 2010;59(9):253–257.
   Google Scholar